RLAY- Relay Therapeutics, Inc.

Across the last three months, Relay Therapeutics, Inc.'s insiders have reduced their positions by a net 8,660 shares worth roughly $162K.

RLAY sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Patel Sanjiv	1.45M	$28.67M	-
Pres	Bergstrom Donald A	409.9K	$8.10M	-
Other	Rahmer Peter	276.6K	$5.47M	-
CFO	Catinazzo Thomas	213.9K	$4.23M	-
Dir	Coats Lonnel	207.9K	$4.11M	-

Buys and sells only

10 filings · page 17

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 28, 2021	Adams Brian71	General Counsel	Sell	293	$35.81	$10,492.33	-1.1%	+4.1%	-54.5%
Jun 28, 2021	Catinazzo Thomas69	Senior Vice President, Finance	Sell	293	$35.81	$10,492.33	-1.8%	+4.1%	-54.5%
Jun 28, 2021	Bergstrom Donald A74	See Remarks	Sell	976	$35.81	$34,950.56	-1.3%	+4.1%	-54.5%
Jun 16, 2021	Bergstrom Donald A74	See Remarks	Sale+OE	42,242	$33.75	$1,425,667.50	-35.4%	+4.6%	-56.5%
Jun 7, 2021	Adams Brian71	General Counsel	Sale+OE	6,500	$35.00	$227,500.00	-20.1%	-3.3%	-53.6%
Jun 7, 2021	Catinazzo Thomas69	Senior Vice President, Finance	Sale+OE	22,500	$35.00	$787,500.00	-58.6%	-3.3%	-53.6%
Apr 26, 2021	Adams Brian71	General Counsel	Sale+OE	6,500	$35.00	$227,500.00	-20.1%	-5.7%	-21.8%
Apr 16, 2021	Bergstrom Donald A74	See Remarks	Sell	56,324	$32.36	$1,822,644.64	-42.2%	-2.3%	-12.4%
Mar 30, 2021	Catinazzo Thomas69	Senior Vice President, Finance	Sale+OE	22,500	$35.00	$787,500.00	-100%	+1.0%	-13.8%
Jan 28, 2021	Adams Brian71	General Counsel	Sale+OE	5,000	$55.05	$275,250.00	-33.3%	-	-